Wellcome Trust
UK charitable foundation funding global health research from a self-owned £35.7bn endowment.
On the record
Checkpoint: Next Annual Report (FY2025/26) showing endowment returns and pace of the £16bn spending commitment
The call
Wellcome's size and independence from external funders make its survival a near-certainty; the open questions sit inside its own staffing and geographic priorities, not in the market.
Wellcome Trust is a charitable foundation that gives away roughly £1.9 billion per year to fund medical research around the world. It is nearly impossible to replace because it has its own massive pile of money (£35.7bn), a perfect credit rating, and no other organization does what it does at this scale. The main question is not whether Wellcome Trust itself will survive, but whether AI tools will let it do grant review and research analysis with fewer staff members, and whether its plan to shift more money toward Africa and Asia changes how it operates.
Why
01
AI pressure: Generative AI tools for grant triage, literature scoping, and portfolio analytics. AI can compress internal grant-ops and analytics roles, but it funds research rather than competing for it, so the institution isn't eaten. Could AI do the core job? Unlikely.
02
Bigger players: None apparent. Wellcome has no market competitors; other large funders like the Gates Foundation operate in parallel, not against it. Could a giant copy it? No, they are blocked.
03
What protects it. A self-funded AAA/Aaa-rated £35.7bn endowment with no external donors and no market rivals to take share from it.
What would change this call
Wellcome's FY2025/26 annual report (~Jan 2027) shows endowment returns and £1.9bn spend pace. Whether the £16bn ten-year spending commitment stays on track amid market conditions.
Progress reports on the geographic pivot toward Africa, South Asia and SE Asia (target 25% by 2030). Whether CEO Røttingen's restructuring shifts headcount and grant activity away from current teams.
Launch and funding disclosures for Wellcome Leap's women's health programs with Pivotal Ventures in 2026. Whether Wellcome's venture-style philanthropy arm is expanding its scope and partnerships.
Progress reports on the geographic pivot toward Africa, South Asia and SE Asia (target 25% by 2030). Whether CEO Røttingen's restructuring shifts headcount and grant activity away from current teams.
Launch and funding disclosures for Wellcome Leap's women's health programs with Pivotal Ventures in 2026. Whether Wellcome's venture-style philanthropy arm is expanding its scope and partnerships.
Key numbers
- Net assets of £35.7bn, up from £33.9bn
- Charitable expenditure rose to £1.916bn
- AAA/Aaa stable rating, leverage 6.7%
Named risks
- Sustained market downturn could pressure endowment returns and the pace of the £16bn 2022 to 2032 spend plan.
- Reputational exposure from historic BP and Shell holdings exceeding £300m as of 2021 despite partial 2022 divestment.
- Execution risk in 2026 announced pivot to concentrate 25% of research in Africa, South Asia, and SE Asia by 2030.
- Role level compression in grant triage, literature scoping, and portfolio analytics from AI adoption.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Gates Foundation | contesting | Larger global health funder by scale as of 2026, coexists rather than competes for grant share |
| Novo Nordisk Foundation | gaining on | Fast growing biomedical funder increasingly prominent in global health philanthropy as of 2026 |
| USAID and Global Fund | gaining on | USAID dissolution in 2025 and 21% drop in global health aid raise relative weight of private funders like Wellcome |
Questions people ask
- Is Wellcome Trust financially healthy in 2026?
- Yes. As of 30 September 2025, Wellcome held total funds of £35.7bn, up from £33.9bn a year earlier, with a £39.9bn investment portfolio and a 10.2% GBP return, plus an AAA/Aaa credit rating, per its January 2026 annual report.
- Who owns Wellcome Trust?
- No one. Wellcome is a private UK charitable trust established in 1936 from Sir Henry Wellcome's legacy, with no shareholders and no external donors. It is entirely self-funded from its own investment endowment, valued at £39.9bn as of 30 September 2025.
- Could AI replace Wellcome Trust?
- No. Wellcome's core function is capital allocation and grant funding backed by a £35.7bn endowment and AAA credit rating, which AI cannot replicate. AI could compress back-office tasks like grant triage across the 4,289 applications received in FY2024/25, not the institution itself.
- Who is Wellcome Trust's biggest competitor?
- Wellcome does not compete for market share; its closest peer is the Bill & Melinda Gates Foundation, historically the largest global health funder, alongside the Novo Nordisk Foundation. These foundations largely coexist rather than compete, per Wellcome's own January 2026 annual report positioning.
- How is Wellcome Trust responding to USAID's collapse and global health funding cuts?
- Wellcome has not announced a specific USAID backfill program, but its January 2026 annual report shows charitable expenditure rising to £1.916bn in FY2024/25 (up from £1.6bn) as global development assistance for health fell roughly 21% in 2025 following USAID's dissolution.
- What is CEO John-Arne Røttingen's strategy for Wellcome Trust?
- Røttingen, who joined as CEO in January 2024, announced in June 2026 a strategic pivot targeting at least 25% of active research investment in Africa, South Asia, and Southeast Asia by 2030, alongside continuing Wellcome's £16bn spending commitment through 2032.
Timeline
- 2026-06-18CEO Røttingen publishes strategy setting 25% Africa/South Asia/SE Asia research target by 2030
- 2026-05-19Wellcome funds $3.2M AI crisis-response training simulator via Kids Help Phone and TMU
- 2026-05-06Natasha Sunderji appointed Chief Strategy Officer
- 2026-01-12FY2024/25 annual report published: £35.7bn total funds, £1.916bn charitable spend
- 2025-12-17Launched Generative AI for anxiety, depression and psychosis grant scheme
- 2025-09-01Wellcome Leap and Pivotal Ventures announce $100m women's health partnership
- 2025-04-01Partnership with UK Government to launch national health data research service
- 2025-01-01Maggy Chan joins as Chief Operating Officer
- 2024-01-01John-Arne Røttingen joins as Chief Executive Officer
Revision history
26 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Wellcome annual report and financial statements 2024/25 (2026-01-12)
- List of wealthiest charitable foundations (2026-07-14)
- Wellcome appoints Dr John-Arne Røttingen as Chief Executive Officer (2023-10-10)
- Wellcome appoints Natasha Sunderji as Chief Strategy Officer (2026-05-06)
- Grant funding data for 2024/25 (2026-06-20)
- Wellcome Trust Annual Report and Financial Statements 2025
- Wellcome Leap
- Wellcome Annual Report 2025 (2026-01-12)
- Generative AI for anxiety, depression and psychosis - Grant Funding (2025-12-17)
- $3.2M Funding Secures AI-Powered Future for Youth Mental Health at Kids Help Phone (2026-05-19)
- Our strategy from John-Arne Rottingen (2026-06-18)
- Analysis of U.S. and Global Fund Funding Reductions in MOU Countries (2026-06-10)